Showing results (101-110 of 646) with videos related to
Sort By:
Pageof 65
Cancer Letters|February 14, 2026
Validation of "SARS-CoV-2 mRNA Vaccines Sensitize Tumors to Immune Checkpoint Blockade" in an Independent Cohort of 4,407 patientsRonen Arbel, Lior Rokach, Talish Razi, et al.European Journal of Haematology|August 1, 2025
Gender Disparities in Health-Related Quality of Life in Patients With Chronic Lymphocytic Leukemia: Impact of Treatment ModalityBushra Mahameed, Giora Sharf, Tamar Tadmor, et al.Ejhaem|July 3, 2026
Vitamin D Supplementation and Treatment-Free Survival in Early-Stage CLL: A Real-World Validation StudyTamar Tadmor, Ronen Arbel, Talish Razi, et al.Hematological Oncology|March 19, 2022
Current perspectives regarding SARS-CoV-2 vaccination in chronic lymphocytic leukemiaStefano Molica, Constantine Tam, Aaron PolliackEuropean Journal of Haematology|June 14, 2002
Development and rapid dissemination of Merkel-cell carcinomatosis following therapy with fludarabine and rituximab for relapsing follicular lymphomaYossi Cohen, Gail Amir, Aaron PolliackLeukemia & Lymphoma|January 8, 2015
Novel therapeutic options for relapsed hairy cell leukemiaPreetesh Jain, Aaron Polliack, Farhad RavandiAnticancer Research|November 7, 2018
Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in IsraelMichal Inbar, Yair Herishanu, Neta Goldschmidt, et al.Clinical Journal of Oncology Nursing|August 5, 2010
A case study progression to multiple myelomaMary Ann Yancey, Adam J Waxman, Ola LandgrenBritish Journal of Haematology|September 4, 2009
Common community acquired infections and subsequent risk of chronic lymphocytic leukaemiaLesley A Anderson, Ola Landgren, Eric A EngelsClinical Lymphoma, Myeloma & Leukemia|March 12, 2013
Etiology of Waldenström macroglobulinemia: genetic factors and immune-related conditionsElisabet E Manasanch, Sigurdur Y Kristinsson, Ola LandgrenPageof 65